Navigation Links
GlaxoSmithKline Announces $500,000 in Fellowships at Stanford Graduate School of Business
Date:5/22/2008

Global Pharmaceutical Company Honors Former CEO with Permanent Legacy at

Alma Mater

PHILADELPHIA, May 22 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE: GSK) today announced the establishment of two fellowships totaling $500,000 in honor of former Chief Executive Officer Jean-Pierre Garnier, to support students enrolled at Stanford Graduate School of Business. Dr. Garnier, who received his Masters of Business Administration from the school in 1974, retired from GSK on May 21, 2008.

Dr. Garnier served as the CEO of GSK since its creation in 2001, steering it through a complex merger and driving the development of one of the strongest new product pipelines in the industry. These funds will provide an ongoing tribute to his success as the leader of the world's second-largest research-based pharmaceutical company.

"Every successful company invests in the business to grow the bottom line," said Sir Christopher Gent, GSK Chairman. "We believe that business should also invest in something less tangible, less quantifiable, but of equal importance-building its reputation with the society it serves. GSK is pleased to honor Dr. Garnier's legacy by providing funds that will help develop the business leaders of tomorrow."

"This generous gift honors an alumnus whose leadership throughout his career has changed lives, changed organizations, and ultimately changed the world," said Robert L. Joss, Dean of the Stanford Graduate School of Business. "The fellowships being established in his honor ensure that Jean-Pierre Garnier will continue to have an impact on shaping the next generation of principled, innovative, and insightful business leaders."

Investing in the Best and Brightest

To remain competitive, Stanford Business School must attract and enroll the best and the brightest students. The school's international reputation as a leader in management education is built on the quality and diversity of its students, whose broad range of experiences and backgrounds fosters a collaborative culture. The GSK funding will provide a permanent legacy to support deserving students enrolled in programs at the school in two ways:

-- A gift of $350,000 has been allocated to establish The JP and Danyele

Garnier Fellowship Fund in the Graduate School of Business. This fund

will provide a permanent legacy from which regular income will be used

to underwrite tuition and fees of deserving candidates pursuing an MBA.

-- A gift of $150,000 has been allocated to establish The JP and Danyele

Garnier Fellowship Fund in the Graduate School of Business Summer

Institute in Entrepreneurship Program. The fund will enable Stanford

Business School to support students in a unique four-week program that

provides non-business school graduate students with a background in

business management fundamentals in finance, marketing, and accounting,

through a highly-interactive experience that also helps develop

foundational business skills, such as developing a business plan,

public speaking, and leadership.

"Not only has JP Garnier's leadership had a significant impact on GSK, it has also been felt by individuals around the world-from the establishment of the GSK African Malaria Partnership and the quest to eliminate lymphatic filariasis in the developing world, to countless community partnerships," Sir Christopher said. "JP Garnier has led GSK in its challenging and inspiring mission: to improve the quality of human life by enabling people to do more, feel better, and live longer. It is our hope that the recipients of these endowments will go on to do the same in their chosen fields."

About GlaxoSmithKline

GlaxoSmithKline, one of the world's leading research-based pharmaceutical and health care companies, is committed to improving the quality of human life by enabling people to do more, feel better, and live longer.

About Stanford Graduate School of Business

The Stanford Graduate School of Business, located in northern California's Silicon Valley, enrolls approximately 740 students in the two-year full-time MBA Program, 105 candidates in the PhD Program, 56 mid-career executives in the 10-month Stanford Sloan Master's Program, and more than 2,000 participants in Executive Education programs designed to enhance executives' professional capabilities. For more information visit: http://www.gsb.stanford.edu.


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. IADR and GlaxoSmithKline Consumer Healthcare announce winners
2. A Statement from GlaxoSmithKline Consumer Healthcare on 2008 Update to the U.S. Public Health Service Guideline on Treating Tobacco Use and Dependence
3. Concern From Doctors Regarding the Cardiovascular Safety of GlaxoSmithKlines Avandia Increases Nine-Fold Following Publication of Meta-Analysis
4. GlaxoSmithKline Confirms Receipt of FDA Letter on Regulatory Reporting
5. Astellas/GlaxoSmithKlines Vesicare Has Advantages Over Pfizers Detrol LA/Detrusitol XL in Reducing Episodes of Urge Urinary Incontinence
6. GlaxoSmithKline Awards Eight Area Healthcare Nonprofits with $40,000 Each in Funding
7. EUSA Pharma Out-Licenses Preclinical-Stage Human Antibody to GlaxoSmithKline for up to $44 Million Plus Royalties
8. Amira Pharmaceuticals and GlaxoSmithKline Enter Global Agreement for FLAP Inhibitor Program
9. AUDIO from Medialink and GlaxoSmithKline: Get Ready to Get Moving to a New You in the New Year
10. Audio from Medialink and GlaxoSmithKline: Cleaning House ... Overhaul Your Fridge and Pantry to Lose Weight
11. VIDEO from Medialink and GlaxoSmithKline: Really Think You Can Lose 30 Pounds in 30 Days?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 2017 , ... Information about the technology: , Otomagnetics has ... prevention of a major side effect of chemotherapy in children. Cisplatin and carboplatin ... cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. Hearing ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a leader in ... 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners were announced ... 2017. , The annual award competition recognizes editorial and design excellence across a range ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the Health ... Miles by Moonlight to raise money for the American Heart Association Heart Walk. Teams ... Teams will work together to keep their treadmills moving for 5 hours. Treadmills will ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... first interactive health literacy software tool, and the Cancer Patient Education Network (CPEN), ... patient education, today announce a new strategic alliance. , As CPEN’s strategic ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... 12, 2017   Divoti USA will engrave ... the standard of the latest FDA requirements, which stipulates new criteria ... Anyone in need of Medical ID jewelry such as Medical ID ... are engraved in terms of the new FDA requirements . ... Divoti offers this dark mark ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/7/2017)... Oct. 6, 2017   Provista, a proven ... $100 billion in purchasing power, today announced a new ... The Newsroom is the online home for ... infographics, expert bios, news releases, slideshows and events. ... a wealth of resources at their fingertips, viewers can ...
Breaking Medicine Technology: